Search Results - Navdeep Pal

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    Overall survival in patients with advanced non-small cell lung cancer with KRAS G12C mutation with or without STK11 and/or KEAP1 mutations in a real-world setting by Cristina Julian, Navdeep Pal, Anda Gershon, Marie Evangelista, Hans Purkey, Peter Lambert, Zhen Shi, Qing Zhang

    Published in BMC Cancer (2023-04-01)
    Get full text
    Article


  2. 2

    Applying the estimand and target trial frameworks to external control analyses using observational data: a case study in the solid tumor setting by Letizia Polito, Qixing Liang, Navdeep Pal, Philani Mpofu, Ahmed Sawas, Olivier Humblet, Kaspar Rufibach, Dominik Heinzmann

    Published in Frontiers in Pharmacology (2024-01-01)
    Get full text
    Article


  3. 3

    Real-World Comparative Effectiveness of First-Line Alectinib Versus Crizotinib in Patients With Advanced ALK-Positive NSCLC With or Without Baseline Central Nervous System Metastas... by Qing Zhang, PhD, Jessica J. Lin, MD, Navdeep Pal, M.B.B.S., MPH, Letizia Polito, PhD, Huong Trinh, MD, Magalie Hilton, MSc, Vlatka Smoljanović, MD, Nino Kurtsikidze, MD, Venice Archer, MD, Matthew G. Krebs, MD, PhD

    Published in JTO Clinical and Research Reports (2023-04-01)
    Get full text
    Article


Search Tools: